This pairing helps lower glucose in two different ways, which can be useful when one medicine is not enough
(2020, March 3)
However, these products (as well as others with demonstrated lipid-lowering properties) may provide a good solution for: (1) statin-ineligible patients receiving early pharmacotherapy of dyslipidaemia, (2) patients declining statin therapy, (3) statin-intolerant patients, and (4) all those who (both in primary and secondary prevention), despite available treatment, still fail to achieve the treatment goal
Graphical Abstract Similar content being viewed by others 1 Introduction Humanity is currently facing an array of pressing public health threats, ranging from the emergence of multidrug-resistant bacteria and rapidly evolving viruses to the growing prevalence of superbugs, drug-resistant parasites, zoonotic infections, and secondary malignancies [1]
Given that both nucleotide and antioxidant pathways are critical in managing oxidative stress, reduced baseline function in these pathways may impair the physiological response to viral infections